Medicure (MCUJF) Amortizatization of Intangibles (2009 - 2026)
Medicure (MCUJF) recorded quarterly Amortizatization of Intangibles of $394500.3 in Q1 2026, down 1.41% quarter-over-quarter from $400134.1 in Q4 2025, and up 6.2% on a YoY basis from $371456.5 in Q1 2025.
Medicure (MCUJF) Amortizatization of Intangibles (2009 - 2026) Analysis & Trends
Medicure's Amortizatization of Intangibles history runs 18 years deep, the most recent figure standing at $394500.3 for Q1 2026.
- In Q1 2026, Amortizatization of Intangibles rose 6.2% year-over-year to $394500.3; the TTM figure through Mar 2026 stood at $1.6 million (up 10.51% YoY), while the FY2025 annual figure was $1.5 million, up 14.91% from the prior year.
- Amortizatization of Intangibles was $394500.3 for Q1 2026 at Medicure, down from $400134.1 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $897859.9 in Q3 2022 to a low of $290526.9 in Q1 2022.
- Historically, Amortizatization of Intangibles has averaged $398583.3 across 5 years, with a median of $354373.7 in 2024.
- The sharpest annual moves came in 2023 and 2025: Amortizatization of Intangibles plunged 64.11% in 2023, then gained 16.11% in 2025.
- A 5-year view of Amortizatization of Intangibles shows it stood at $897859.9 in 2022, then tumbled by 64.17% to $321726.6 in 2023, then advanced by 15.26% to $370809.9 in 2024, then climbed by 7.91% to $400134.1 in 2025, then declined by 1.41% to $394500.3 in 2026.
- The last three Amortizatization of Intangibles figures came in at $394500.3 (Q1 2026), $400134.1 (Q4 2025), and $392382.9 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 1.30 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 242,000.00 |
| 10 | Medicure | - | - | 2.57 Mn | 394,500.28 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 394,500.28 |
| Mar 31, 2026 | 394,500.28 |
| Dec 31, 2025 | 400,134.15 |
| Dec 31, 2025 | 400,134.15 |
| Sep 30, 2025 | 392,382.90 |
| Sep 30, 2025 | 392,382.90 |
| Jun 30, 2025 | 376,012.21 |
| Jun 30, 2025 | 376,012.21 |
| Mar 31, 2025 | 371,456.48 |
| Mar 31, 2025 | 371,456.48 |
| Dec 31, 2024 | 370,809.85 |
| Dec 31, 2024 | 370,809.85 |
| Sep 30, 2024 | 337,937.62 |
| Sep 30, 2024 | 337,937.62 |
| Jun 30, 2024 | 334,131.23 |
| Jun 30, 2024 | 334,131.23 |
| Mar 31, 2024 | 326,529.81 |
| Mar 31, 2024 | 326,529.81 |
| Dec 31, 2023 | 321,726.56 |
| Dec 31, 2023 | 321,726.56 |